Pathology Review: Hematopathology, Head and Neck Pathology and Fine Needle Aspirations for the General Pathologist

  • NH_0000005299
90 $

Pathology Review: Hematopathology, Head and Neck Pathology and Fine Needle Aspirations for the General Pathologist

Educational Objectives

At the completion of this CME teaching activity, you should be able to:
  • Recognize the different types of tissue fragments in FNAB specimens; recognize several cytomorphologic patterns of FNAB specimens; and render a diagnosis based on a pattern recognition of FNAB specimen.

 

 
  • Recognize the basic architectural patterns seen in thyroid aspirates and be able to identify and diagnose common benign and malignant thyroid lesions.
  • Render a diagnosis based on pattern recognition of thyroid FNAB specimens and formulate a broad differential diagnosis.
  • Recognize the basic architectural pattern seen with salivary gland aspirates and be able to identify and diagnose common benign and malignant salivary gland lesions.
  • Render a diagnosis based on pattern recognition and salivary gland FNAB specimens and formulate a broad differential diagnosis.
  • Describe the basic technique and pitfall avoidance of fine needle aspiration biopsy performance.
  • Discuss the new WHO Criteria for the diagnosis of Myeloid Neoplasms in blood and bone marrow.
  • Apply strategies for integrating Molecular and Genetic testing into routine clinical practice.
  • Achieve a better understanding of Salivary Gland Pathology in the Molecular Era.
  • Recognize lesions of the Sinonasal tract and differentiate bad actors from benign lesions.
  • Achieve a more practical approach to Lymphoid Disorders in Blood and Bone Marrow.
  • Differentiate Mucosal Lesions of the Head and Neck.
  • Understand age-based normal lymphoid parameters.
  • Learn key features/clues to unique lymphoid disorders in blood and bone marrow.
  • Appreciate new WHO 2016 criteria and testing recommendations for acute + chronic lymphoid neoplasms.
  • Understand progress in AML classification.
  • Develop list of required tests in AML, MDS, MDS/MPN and MPN.
  • Recognize newly proposed AML subtypes and newly proposed entities for other categories of myeloid neoplasms.
  • Appreciate key new molecular tests essential in the evaluation of myeloid neoplasms.

 

Topics & Speakers:

Session 1

FNA of the Salivary Glands
Osama M.A. Abdelatif, M.D.

FNA of the Thyroid
Osama M.A. Abdelatif, M.D.

Session 2

FNA Diagnosis by Pattern Recognition
Osama M.A. Abdelatif, M.D.

Session 3

Overview of Acute Myeloid Leukemia and Chronic Myeloid Neoplasms: 2016 Strategies
Kathryn Foucar, M.D.

Session 4

Myeloplastic Syndromes and Mimics: New Names, New Traps
Kathryn Foucar, M.D.

Session 5

Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, and New Acquaintances
Jennifer L. Hunt, M.D.

Session 6

Lesions of the Sinonasal Tract: From Banal to Benign to Bad Actors
Jennifer L. Hunt, M.D.

Session 7

Lymphoid Disorders in Blood and Bone Marrow: A Stepwise Diagnostic Approach (WHO 2016) – Part 1
Kathryn Foucar, M.D.

Lymphoid Disorders in Blood and Bone Marrow: A Stepwise Diagnostic Approach (WHO 2016) – Part 2
Kathryn Foucar, M.D.

Session 8

Lymphoid Disorders in Blood and Bone Marrow: A Stepwise Diagnostic Approach (WHO 2016) – Part 3
Kathryn Foucar, M.D.

Session 9

Pearls and Pitfalls in Early Neoplasia of the Head and Neck
Jennifer L. Hunt, M.D.

Session 10

Potpourri of Head and Neck Cancer
Jennifer L. Hunt, M.D.